¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"life cycle stages"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • life expectancy
    ±â´ë¿©¸í
  • life instinct
    »îº»´É, »ýº»´É
  • life line
    1. »ý¸íÀüÈ­ 2. »ý¸í±¸Á¶¼±
  • life style disease
    »ýȰ½À°üº´
  • life table
    »ý¸íÇ¥
  • mean life expectancy
    Æò±Õ¿©¸í
  • mean life span
    Æò±Õ¼ö¸í
  • shelf life
    ÀúÀå±â°£, º¸°ü±â°£
  • anovulatory cycle
    ¹«¹è¶õ¿ù°æÁÖ±â
  • anovulatory menstrual cycle
    ¹«¹è¶õ¿ù°æÁÖ±â
  • aberrant cycle
    ÀÌ»óÁÖ±â
  • biologic cycle
    »ý¹°ÇÐÀûÁÖ±â
  • citric acid cycle
    ½ÃÆ®¸£»êȸ·Î, ±¸¿¬»êȸ·Î
  • carbon dioxide cycle
    ÀÌ»êȭź¼Òȸ·Î
  • Cori cycle
    ÄÚ¸®È¸·Î
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intrauterine life
    Àڱó»»ýȰ
  • life instinct
    »îº»´É, »ýº»´É
  • life
    »ýȰ
  • life annuity
    Á¾½Å¿¬±Ý
  • life expectancy
    ±â´ë¿©¸í
  • life line
    »ý¸íÀüÈ­, »ý¸í±¸Á¶¼±
  • life table
    »ý¸íÇ¥
  • life insurance medicine
    »ý¸íº¸ÇèÀÇÇÐ
  • life insurance method
    »ý¸íº¸Çè¹ý
  • physical half life
    ¹°¸®Àû¹Ý°¨±â
  • shelf life
    ÀúÀå±â°£, º¸°ü±â°£
  • mean life span
    Æò±Õ¼ö¸í
  • aberrant cycle
    ÀÌ»ó¼øÈ¯
  • anovulatory cycle
    ¹«¹è¶õ¿ù°æÁÖ±â
  • anovulatory menstrual cycle
    ¿ù°æÁÖ±â, ¹«¹è¶õ¼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Krebs cycle
    Å©·¹ºêÁÖ±â
  • aberrant cycle
    ÀÌ»ó¼øÈ¯(ì¶ßÈâàü»)
  • anovulatory cycle
    ¹«¹è¶õ ¿ù°æÁÖ±â(ÙíÛÉÕ°êÅÌèñ²Ñ¢)
  • anovulatory cycle
    ¹«¹è¶õ¼º ÁÖ±â(ÙíÛÉÕ°àõ ñÎÑ¢)
  • anovulatory cycle
    ¹«¹è¶õ¼º ÁÖ±â.
  • gastric cycle
    À§ÁÖ±â(êÖñÎÑ¢).
  • genesial cycle
    ¿©ÀÚ»ý½ÄÁÖ±â.
  • glucose lactate cycle
    ±Û·çÄÚ¿À½º¶ôÆ®»ê ȸ·Î.
  • gravitational cycle
    ÀÓ½ÅÁÖ±â
  • growth cycle
    Áõ½ÄÁÖ±â
  • hair cycle
    ¸ð¹ßÁÖ±â(Ù¾ ñÎÑ¢)
  • hydrogen cycle
    ¼ö¼Òȯ(¡­ü»), ¼ö¼Ò°í¸®.
  • infection cycle
    °¨¿°»ç, °¨¿°È¯
  • photochemical cycle
    ±¤È­Çаæ·Î(¡­ÌèÖØ).
  • pulse cycle
    ¸Æ¹ÚÁÖ±â(ØæÚÑñ²Ñ¢).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • biological half life
    »ý¹°ÇÐÀû ¹Ý°¨±â(¡­ÚâÊõÑ¢)
  • biological half life
    [½ÅÀå,¹ÙÀÌ,°£È£]»ý¹°ÇÐÀû ¹Ý°¨±â(¡­ÚâÊõÑ¢).
  • complete life table
    ¿ÏÀü»ý¸íÇ¥(ÊÙË×ËḬ̂).
  • corrected life birth rate
    Á¤Á¤Ãâ»ý·ü(ÊÙ̧Ë×Ëô).
  • corrected life birth rate
    Á¤Á¤Ãâ»ý·ü(¡­õóßæëÒ).
  • counterculture life-style
    ¿ª¹®È­-»ýȰ ÇüÅÂ(æ½Ùþûù-ßæüÀû¡÷¾)
  • duration of life
    ¼ö¸í(ËÛËÎ).
  • effective half life
    À¯È¿¹Ý°¨±â.
  • effective half-life
    À¯È¿¹Ý°¨±â
  • elimination half-life
    ¼Ò½Ç¹Ý°¨±â.
  • embryonic life
    ¹èÅ»ýȰ(ÛÏ÷ÃßæüÀ).
  • expectancy of life
    ¿©¸í(ËçËÎ).
  • expectation of life
    ¿©¸í.
  • half-life
    ¹Ý°¨±â
  • intrauterine life
    Àڱó»»ýȰ(¡­ßæüÀ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cell cycle
    ¼¼Æ÷ÁÖ±â(á¬øàñÎÑ¢)
  • citrate cycle
    ½ÃÆ®¸£»êȸ·Î(ß«üÞÖØ)
  • citrate-pyruvate cycle
    ½ÃÆ®¸£»ê(ß«)-ÇǸ£ºê»êȸ·Î(ß«üÞÖØ)
  • citric acid cycle
    ½ÃÆ®¸£»êȸ·Î(ß«üÞÖØ)
  • Cori cycle
    ÄÚ¸® ȸ·Î(üÞÖØ)
  • cycle
    "°í¸®, ȸ·Î(üÞÖØ), ȯ»ó(ü»ßÒ)"
  • dicarboxylic acid cycle
    "ÀÌ(ì£)Ä«¸£º¹½Ç»ê(ß«) ȸ·Î(üÞÖØ), (ÔÒ) glyoxylate cycle"
  • elongation cycle
    ¿¬ÀåÁÖ±â (æÅíþñÎÑ¢)
  • futile cycle
    ¹«ÀÍ È¸·Î(ÙíìÌüÞÖØ)
  • generation cycle
    ¼¼´ë ÁÖ±â(á¦ÓÛñÎÑ¢)
  • glucose-alanine cycle
    ±Û·çÄÚ½º-¾Ë¶ó´Ñ ȸ·Î(üÞÖØ)
  • ¥ã-glutamyl cycle
    ¥ã-±Û·çŸ¹Ð ȸ·Î(üÞÖØ)
  • glycine-allantoin cycle
    ±Û¶óÀ̽Å-¾Ë¶õÅäÀΠȸ·Î(üÞÖØ)
  • glycine-succinate cycle
    ±Û¶óÀ̽Å-¼®½Å»ê(ß«) ȸ·Î(üÞÖØ)
  • glycolic acid cycle
    ±Û¶óÀÌÄÝ»ê(ß«) ȸ·Î(üÞÖØ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LCP Disease Legg-Calve-Perthes Disease
  ? Stages of LCP Disease(= Juvenile Idiopathic AVN)
&nb...
FAST flow-assisted, short-term [balloon catheter]; fluorescent antibody staining technique; fluoro-allerg...
T + 1, T + 2, T + 3 first, second, and third stages of increased intraocular tension
T-1, T-2, T-3 first, second, and third stages of decreased intraocular tension
ALS acute lateral sclerosis; advanced life support; afferent loop syndrome; amyotrophic lateral sclerosi...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CL Cycle Length
SCL Sinus Cycle Length
SSC Stretch-shortening cycle
CDC2 cell division cycle 2
C cycle
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • life insurance
    »ý¸í º¸Çè
    »ç¶÷ÀÇ »ç¸Á ¶Ç´Â »ýÁ¸À» º¸Çè»ç°í·Î ÇÏ´Â ÀÏüÀÇ º¸Çè. Àκ¸ÇèÀÇ ´ëÇ¥ÀûÀÎ °ÍÀÌ´Ù. º¸ÇèÀÚ°¡ º¸Çè°è¾àÀÚ ¶Ç´Â Á¦3ÀÚÀÇ »ý»ç¿¡ °üÇÏ¿© ÀÏÁ¤ÇÑ ±Ý¾×
  • life insurance medicine
    »ý¸í º¸Çè ÀÇÇÐ
  • life phase
    »ýȰ»ó
  • life span
    ¼ö¸í
    °³Ã¼ÀÇ »ýÁ¸ ±â°£.
  • life support
    »ý¸í À¯Áö
  • mean life expectancy
    Æò±Õ ¿©¸í
  • quality of life
    »îÀÇ Áú
  • aberrant cycle
    ÀÌ»ó ¼øÈ¯
    ½Â¸ðÆÇ ÇùÂø ¶§¹®¿¡ °£ Ç÷°ü°ú ±â°üÁö Ç÷°üÀÌ ±³ÅëÇÏ´Â °Í.
  • biologic cycle
    »ý¹°ÇÐÀû ÁÖ±â
  • cardiac cycle
    ½ÉÀå ÁÖ±â, ½É ÁÖ±â
    ½É¹æ°ú ½É½ÇÀº ½Ã°£ÀûÀ¸·Î µ¿½Ã´Â ¾Æ´ÏÁö¸¸ ¼öÃà°ú È®ÀåÀ» °ÅµìÇϰí ÀÖ°í, ÀÌ ÁÖ±âÀûÀΠȰµ¿ÀÌ ½É¹Úµ¿ÀÌ°í ½É¹Úµ¿ÀÇ Áֱ⸦ ½ÉÁÖ±â¶ó°í ÇÑ´Ù.
  • cardic cycle
    ½ÉÁÖ±â
    ¿Ï°áµÈ ½É¿îµ¿ ¶Ç´Â ½É¹Ú. ¾î¶² ½É¹ÚÀÇ ½ÃÀÛºÎÅÍ ´ÙÀ½ ½É¹ÚÀÇ ½ÃÀÛ±îÁöÀÇ ±â°£. ¼öÃß±â, È®Àå±âÀÇ ¿îµ¿°ú ±×°ÍµéÀÇ °£°Ý.
  • cash cycle
    ÀÚ±Ý È¸Àü
    ¿øÀÚÀçÀÇ ±¸¸Å·ÎºÎÅÍ ÃÖÁ¾ »ý»ê¹°ÀÇ ÆÇ¸Å¿¡¼­ ¹ß»ýÇÏ´Â °è»êÀÇ Çհ踦 ³¾ ¶§±îÁö °É¸®´Â ½Ã°£.
  • cell cycle-non specific
    ¼¼Æ÷ Áֱ⠺ñƯÀ̼º Á¦Á¦
  • chronic pain cycle
    ¸¸¼º µ¿Åë ¼øÈ¯
  • curing cycle
    ¿Â¼º±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
RNA life <biology, molecular biology> A hypothetical life form lacking DNA and protein which may have existed on early earth and in which RNA served both a genetic coding and a catalytic function.
(23 Aug 1998)
physical half-life The time required for half the atoms of a radionuclide to undergo disintegration.
(05 Mar 2000)
wrongful life In civil law a cause of action which alleges that a defendant has wrongfully caused a child to be born.
(12 Dec 1998)
postnatal life That interval of life after birth; in man, usually divided into periods: neonatal, infancy, childhood, adolescence, and adulthood.
(05 Mar 2000)
half-life 1. <pharmacology> The period over which the concentration of a specified chemical or drug takes to fall to half its original concentration in the specified fluid or blood.
2. <radiobiology> The time required to reduce the amount of a radionuclide to one-half the amount originally present. Physical or radioactive half-life refers to reduction of activity by radioactive decay, biological half-life refers to biological elimination from the body and effective half-life refers to the combined action of radioactive decay and biological elimination.
(16 Dec 1997)
prenatal life That interval of life between conception and birth; in humans, usually divided into embryonic and foetal periods.
(05 Mar 2000)
sexual life In psychiatry and psychoanalysis, the specifically erotic or sexual interests, fantasies, inclinations, and conduct of the patient.
(05 Mar 2000)
drug half-life The amount of time it takes for one-half of an administered drug to be lost through biological processes (metabolism and elimination).
(27 Sep 1997)
immediately dangerous to life concentration <radiobiology> This is a regulatory value defined as the maximum exposure concentration in the workplace from which one could escape within 30 minutes without suffering symptoms which would interfere with escaping and without suffering any irreversible health effects.
(04 Nov 1997)
quality adjusted life year A year of life adjusted for its quality or its value. A year in perfect health is considered equal to 1.0 qaly. The value of a year in ill health would be discounted. For example, a year bedridden might have a value equal to 0.5 qaly.
A measurement index derived from a modification of standard life-table procedures and designed to take account of the quality as well as the duration of survival. This index can be used in assessing the outcome of health care procedures or services.
(12 Jul 2000)
quality of life Refers to the level of comfort, enjoyment, ability to pursue daily activities. Often used in discussions of treatment options.
(16 Dec 1997)
insurance, life Insurance providing for payment of a stipulated sum to a designated beneficiary upon death of the insured.
(12 Dec 1998)
economic value of life The evaluation of the monetary value of a life lost or a life saved.
(12 Dec 1998)
effective half-life <radiobiology> Time required for a radioactive substance contained in a biological system (such as a person or an animal) to reduce its radioactivity by half, as a combination result of radioactive decay and biological elimination from the system.
(09 Oct 1997)
elimination half-life <pharmacology> The time it takes for the body to eliminate or breakdown half of a dose of a pharmacologic agent.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nitrogen cycle
    Áú¼Ò ¼øÈ¯
  • solar cycle
    ÅÂ¾ç ¼øÈ¯±â;28 ÁÖ³â
  • trade cycle
    °æ±â ¼øÈ¯
  • for one's life
    ÇÊ»çÀûÀ¸·Î
  • for the life of me
    ¾Æ¹«¸®Çصµ
  • half life
    ¹Ý°¨±â
  • life
    »ý¸í,ÀÏ»ý,Àλý,»ýȰ
  • life-giving
    »ý¸íÀ» ÁÖ´Â
  • life-size
    ½Ç¹° Å©±âÀÇ
  • life-sized
    ½Ç¹°´ëÀÇ
  • civil life
    »çȸ(°ø¹Î)»ýȰ;½Ã¹Î(Æò¹Î)»ýȰ(±ºÀÎ »ýȰ¿¡ ´ëÇÏ¿©)
  • future life
    Àú¼¼»ó;³»¼¼;¿µ°è
  • good life
    Æò±Õ ¼ö¸í±îÁö »ì °¡¸ÁÀÌ ÀÖ´Â »ç¶÷
  • half life
    (¹Ý»ç´É)¹Ý°¨±â
  • high life
    »ó·ù »çȸ(ÀÇ »ýȰ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á